BTAI
BioXcel Therapeutics, Inc. Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
BioXcel Therapeutics, Inc. (BTAI) closed at $1.50 as of 2026-02-02, trading 98.6% below its 200-week moving average of $109.07. This places BTAI in the extreme value zone. The stock is currently moving closer to the line, down from -98.6% last week. The 14-week RSI sits at 39, indicating neutral momentum.
Over the past 365 weeks of data, BTAI has crossed below its 200-week moving average 5 times. On average, these episodes lasted 45 weeks. Historically, investors who bought BTAI at the start of these episodes saw an average one-year return of +310.8%.
With a market cap of $33 million, BTAI is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. The stock trades at -0.3x book value.
Share count has increased 77.4% over three years, indicating dilution.
Over the past 7.1 years, a hypothetical investment of $100 in BTAI would have grown to $1, compared to $276 for the S&P 500. BTAI has returned -47.3% annualized vs 15.4% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: BTAI vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After BTAI Crosses Below the Line?
Across 5 historical episodes, buying BTAI when it crossed below its 200-week moving average produced an average return of +181.8% after 12 months (median +78.0%), compared to +10.2% for the S&P 500 over the same periods. 60% of those episodes were profitable after one year. After 24 months, the average return was +136.6% vs +39.8% for the index.
Each line shows $100 invested at the moment BTAI crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
BTAI has crossed below its 200-week MA 5 times with an average 1-year return of +310.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2019 | Mar 2019 | 1 | 2.6% | +325.5% | -98.8% |
| Aug 2019 | Aug 2019 | 1 | 2.9% | +474.9% | -98.9% |
| Sep 2019 | Dec 2019 | 13 | 52.1% | +473.7% | -98.8% |
| Nov 2021 | Jan 2023 | 59 | 58.6% | -30.9% | -99.6% |
| Mar 2023 | Ongoing | 153+ | 99.3% | Ongoing | -99.5% |
| Average | 45 | — | +310.8% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02